Evidence map›Paper›PMID 40986886›Full record

ArticleJMIR medical informatics2025

Predicting Lymph Node Metastasis in Rectal Cancer: Development and Validation of a Machine Learning Model Using Clinical Data.

Wei Hou, Chuangwei Li, Zhen Wang, Wanqin Wang, Shouhong Wan, Bingbing Zou

Abstract readValidation Study
In one paragraph

Article in JMIR medical informatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Wei Hou *Department of General Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, 230022, China.ORCID 0009-0000-3244-3090
Chuangwei Li *Department of General Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, 230022, China.ORCID 0009-0007-2389-3226
Zhen WangDepartment of General Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, 230022, China.ORCID 0009-0006-7204-6368
Wanqin WangInstitute of Artificial Intelligence, Hefei Comprehensive National Science Center, Hefei, China.ORCID 0009-0000-9642-3822
Shouhong WanInstitute of Artificial Intelligence, Hefei Comprehensive National Science Center, Hefei, China.ORCID 0009-0002-4368-8223
Bingbing ZouDepartment of General Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, 230022, China.ORCID 0009-0004-4804-6902

Funding

Department of Education 2023JYXM1111
6 · The paper itself

Abstract

Background: Rectal cancer (RC) is a common malignant tumor, with lymph node metastasis (LNM) being a critical determinant of patient prognosis. Traditional diagnostic methods have limitations, necessitating the development of predictive models using clinical data. Objective: This study aimed to construct and validate machine learning (ML) models to predict LNM risk in patients with RC based on clinical data. Methods: Retrospective data from 2454 patients with RC (SEER [Surveillance, Epidemiology, and End Results] database) were split into training (n=1954) and internal validation (n=500) sets. An external cohort (n=500) was obtained from the First Affiliated Hospital of Anhui Medical University. Lymph node features identified via computed tomographic scans were integrated with clinicopathological data. Variables were selected using LASSO (Least Absolute Shrinkage and Selection Operator), followed by univariate and multivariate logistic regression. Eleven ML models (Logistic Regression, K-Nearest Neighbors, Extremely Randomized Trees, Naive Bayes, XGBoost [XBG], Light Gradient Boosting Machine, Multilayer Perceptron, Gradient Boosting, Support Vector Machine, Random Forest, and Ada-Boost) were evaluated via area under the receiver operating characteristic curve (AUC), calibration curves, and decision curve analysis. Results: LNM prevalence was 26.9% (training), 27% (internal validation), and 81% (external validation). Independent LNM predictors included tumor grade, clinical T stage, N stage, tumor length, neural invasion, and total lymph nodes. Internal validation AUC ranged from 0.859 to 0.964; external validation AUC was 0.735-0.838. In the internal validation set, Random Forest and Extremely Randomized Trees achieved the highest AUC (0.964, 95% CI 0.950-0.978), while XGB demonstrated superior cross-cohort stability (AUC 0.942, 95% CI 0.925-0.959). For external validation, Gradient Boosting had the highest AUC (0.838, 95% CI 0.801-0.875), followed by XGB (0.832, 95%CI 0.794-0.869). XGB showed minimal calibration error with curves closest to the ideal diagonal and yielded the highest net benefit in decision curve analysis across critical thresholds. Conclusions: This study successfully developed and validated 11 ML models to predict LNM risk in RC. The XGB model was optimal, achieving an AUC >0.9 in 10 internal models and an AUC >0.8 in 7 external models. The identified predictors of LNM can facilitate early diagnosis and personalized treatment, highlighting the potential of integrating computed tomographic scan data with clinicopathological findings to build effective predictive models.

Indexed as

Lymphatic MetastasisMachine LearningRectal NeoplasmsAgedFemaleHumansMaleMiddle AgedRetrospective StudiesROC Curveclinical data, prognosislymph node metastasismachine learning modelprediction modelsrectal cancerXGBoost

Identifiers

PMID40986886
PMCPMC12456929

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.